Latest news
Stay in the know about our progress, and visit our Newsroom
Caring for patients is a privilege. Whether you are an academic, physician, nurse, patient advocate, pharmacist, caregiver, a government official or pharmaceutical company: we believe pioneering for patients is our shared responsibility. That is why we seek to collaborate with all stakeholders in the healthcare system, on all levels, aiming to improve the quality of live for patients.
Are you a healthcare professional? Do you have questions about our therapeutic areas and indications (inflammation, rheumatoid arthritis, ulcerative colitis)? Looking for medical education? Wondering about our presence at congresses and events? Searching for details about our products? Or do you have inquiries for our medical team?
Important note: by clicking the link below, you will leave this website and will be redirected to our online portal for healthcare professionals. By continuing, you confirm that you are a healthcare professional.
Clinical trials are a critical part of our journey to evaluate investigational treatments and seek approval from health authorities such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
At Galapagos, we organize clinical trials in various therapeutic areas, conducting research that paves the way for innovative solutions.
Visit our Clinical Trials portal to explore the fascinating world of clinical trials. Discover how they’re set up and gain insights into what’s essential when considering participation.
All about Galapagos
Everything you need to know about Galapagos in one slide deck.
From early discovery to commercialization: discover our pipeline in immunology and oncology!
Work with us
We are looking for new licensing opportunities and partnerships to build our pipeline. Do you want to pioneer for patients, together?
Stay in the know about our progress, and visit our Newsroom
Read more about how we are #LivingInnovation in our stories
Looking for information about our company, our stock and our financials?